Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine

Arthritis and Rheumatism

Volumn 40, Issue 5, 1997, Pages 927-935

  Meng, Xue Wei ^a   Feller, John M ^a,b   Ziegler, John B ^a   Pittman, Sally M ^a   Ireland, Christine M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; HYDROXYCHLOROQUINE;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSIS; DNA CLEAVAGE; DOSE RESPONSE; DRUG EFFECT; ETIOLOGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 1842289274     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400522     Document Type: Article

References (44)

1. Dubois EL: Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 8:33-51, 1978
2. Mackenzie AH, Scherbel AL: Chloroquine and hydroxychloroquine in rheumatological therapy. Clin Rheum Dis 6:545-566, 1980
3. Ziegler HK, Unanue ER: Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A 79:175-179, 1982
4. Grey HM, Chesnut R: Antigen processing and presentation to T cells. Immunol Today 6:101-110, 1985
5. Guidos C, Wong M, Lee KC: A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T cells proliferative to various antigens. J Immunol 133:1179-1185, 1984
6. Mackenzie AH: Pharmacological actions of 4-aminoquinoline compounds. Am J Med 75:5-10, 1983
7. Cohen SN, Yielding KL: Further studies on the mechanism of action of chloroquine: inhibition of DNA and RNA polymerase reaction (abstract). Arthritis Rheum 7:302, 1964
8. Salmeron G, Lispsky PE: Immunosuppressive potential of antimalarials. Am J Med 75 (suppl):19-24, 1983
9. Wollheim FA, Hanson A, Luurell CB: Chloroquine treatment in rheumatoid arthritis. Scand J Rheumatol 7:171-176, 1978
10. Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L: Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin-1 alpha and interleukin-6 in human monocytes and T cells. J Rheumatol 20:803-808, 1993
11. Picot S: Chloroquine inhibits tumour necrosis factor production by human macrophages in vitro. J Infect Dis 164:830-831, 1991
12. Zhu X, Ertel W, Ayala A, Morrison MH, Perrin MM, Chaudry IH: Chloroquine inhibits macrophage tumour necrosis factor-α mRNA transcription. Immunology 80:122-126, 1993
13. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77, 1984
14. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is assodated with endogenous endonuclease activation. Nature 284:555-556, 1980
15. Cohen JJ, Duke RC: Glucocorticoid activation of a calcium-dependent endonuclease in the thymocyte leads to cell death. J Immunol 132:38-42, 1984
16. Sellins KS, Cohen JJ: Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139:3199-3206, 1987
17. Hinchliffe JR: Cell death in embryogenesis. In, Cell Death in Biology and Pathology. Edited by ID Bowen, RA Lockshin. London, Chapman and Hall, 1981
18. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279-289, 1994
19. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491, 1995
20. Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685-3692, 1994
21. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37:1423-1430, 1994
22. Mountz JD, Wu J, Cheng J, Zhou T: Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 37:1415-1420, 1994
23. Talal N: Oncogens, autogenes, and rheumatic diseases. Arthritis Rheum 37:1421-1422, 1994
24. Arends MJ, Wyllie AH: Apoptosis: mechanism and roles in pathology. Int Rev Exp Pathol 32:223-254, 1991
25. Nicoletti I, Migliorati G, Pagliacci MC, Riccardi C: A rapid simple method for measuring apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
26. Schmid I, Uittenbogaart CH, Giorgi J: A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 12:279-285, 1991
27. Fraker PJ: Study apoptosis in heterogeneous population: two colour analysis. Methods Cell Biol 46:69-73, 1995
28. Cotter TG, Lennon SV, Glynn JG, Martin SJ: Cell death via apoptosis and its relationship to growth development and differentiation of both tumour and normal cells. Anticancer Res 10: 1153-1160, 1990
29. Wyllie AH: Cell death: a new classification separating apoptosis from necrosis. In, Cell Death in Biology and Pathology. Edited by ID Bowden, RA Lockshin. London, Chapman and Hall, 1981
30. Elkon KB: Apoptosis in SLE: too little or too much? Clin Exp Rheumatol 12:553-559, 1992
31. Watanabe-Fukunaga R, Brannan CI, Copelund NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediated apoptosis. Nature 356:314-317, 1992
32. Adachi MR, Watanabe-Fukunaga R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen of Ipr mice. Proc Natl Acad Sci U S A 90:1756-1760, 1993
33. VanHouten N, Budd RC: Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol 149:2513-2517, 1992
34. French JK, Hurst NP, O'Donnel ML, Betts WH: Uptake of chloroquine and hydroxychloroquine by human blood leukocytes in vitro: relation to cellular concentration during antirheumatic therapy. Ann Rheum Dis 46:42-45, 1987
35. Gottlieb RA, Nordberg J, Skowronski E, Babior BM: Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci U S A 93:654-658, 1996
36. Hockenbery D, Nunez G, Milliman C, Schreber R, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
37. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE: The protooncogene Bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 60:1183-1186, 1993
38. Malorni W, Rivabene R, Santini MT, Raradisi S, Francesca I: Down-regulation of CD4 antigen during programmed cell death U937 cells. FEBS Lett 336:335-339, 1993
39. Tasai WP, Nara PL, Kunig HK, Oroszlin S: Inhibition of human immunodeficiency virus by chloroquine. AIDS Res Hum Retroviruses 6:481-488, 1990
40. Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L: Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cell and monocytes. AIDS Res Hum Retrovirus 9:91-98, 1993
41. Sperber K, Louie M, Proner J, Kraus T, Sapira E, Lin S, Stecher V, Mayer L: Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther 17:622-636, 1995
42. Ornstein MH, Sperber K: The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum 39:157-161, 1996
43. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
44. Kroemer G, Martinez-A C: Pharmacological inhibition of programmed lymphocyte death. Immunol Today 15:235-242, 1994